Safety of therapeutic methylphenidate in adults: a systematic review of the evidence
about
Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adultsInhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addictionDevelopment of a physiologically based model to describe the pharmacokinetics of methylphenidate in juvenile and adult humans and nonhuman primatesThe interactive effects of methylphenidate and ethanol on ethanol consumption and locomotor activity in miceInfluence of sensitization on the discriminative stimulus effects of methylphenidate in mice.Transdermal and oral dl-methylphenidate-ethanol interactions in C57BL/6J mice: transesterification to ethylphenidate and elevation of d-methylphenidate concentrationsLack of neuronal nitric oxide synthase results in attention deficit hyperactivity disorder-like behaviors in mice.Effects of Fatty Acid Amide Hydrolase (FAAH) Inhibitors in Non-Human Primate Models of Nicotine Reward and RelapseLong-term (1 year) safety and efficacy of methylphenidate modified-release long-acting formulation (MPH-LA) in adults with attention-deficit hyperactivity disorder: a 26-week, flexible-dose, open-label extension to a 40-week, double-blind, randomiseInteractive effects of methylphenidate and alcohol on discrimination, conditioned place preference and motor coordination in C57BL/6J miceMethylphenidate in mania project (MEMAP): study protocol of an international randomised double-blind placebo-controlled study on the initial treatment of acute mania with methylphenidate.Should physicians prescribe cognitive enhancers to healthy individuals?Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder.Effect of methylphenidate in patients with cancer-related fatigue: a systematic review and meta-analysis.Treatment discontinuation with methylphenidate in adults with attention deficit hyperactivity disorder: a meta-analysis of randomized clinical trials.Cancer-related fatigue and its impact on functioning.Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder.Metabolomics of Methylphenidate and Ethylphenidate: Implications in Pharmacological and Toxicological Effects.Long-term treatment with methylphenidate for fatigue after traumatic brain injury.The discriminative stimulus properties of methylphenidate in C57BL/6J mice.Amphetamine, catatonic depression, and heart transplant: a case report.Phase II, randomised, double-blind, placebo-controlled trial of methylphenidate for reduction of fatigue levels in patients with prostate cancer receiving LHRH-agonist therapy.Locus coeruleus neuronal activity correlates with behavioral response to acute and chronic doses of methylphenidate (Ritalin) in adolescent rats.Psychostimulant treatment of combat-related posttraumatic stress disorder.Symptomatic Treatment of Vascular Cognitive Impairment (STREAM-VCI): Protocol for a Cross-Over Trial.Symptomatic Treatment of Vascular Cognitive Impairment (STREAM-VCI): Protocol for a Cross-Over Trial (Preprint)
P2860
Q28246506-EAEA7962-4BB9-46F3-94B3-CF9519BDC734Q28283718-05F062F4-5359-4063-A18F-D296007211D6Q28393582-BA7B3CF5-5522-4B1A-9F0F-89CC4D895D63Q33822439-A24936DC-78E9-4ECD-A29F-17CEBC8EBFEBQ34437715-0965B155-53F7-4E97-BF52-ED5A77B695F9Q35600580-86C795D2-51EF-4721-86A2-2304171CB787Q35910964-0503D5D6-4175-46F6-8C69-8CC493BDB5F5Q36184904-EFDD49EF-CE7E-412C-9613-D786776CEB19Q36364178-31AA1E8E-F2E5-4245-9058-1EDD5FA89483Q36539767-552E4543-00DF-47C5-BF7A-2559AACD6772Q36687442-6D24AE77-6EE4-4394-947D-DAB5A20E5883Q37141975-5A7AB62F-0640-4710-ACFA-9E60C17B792BQ37354631-056C7531-77DC-4F4B-AD37-3B1DA2B7934AQ37452620-C855384A-2185-47EB-ABA6-D01F58CE29ACQ38043921-B31567F3-94D2-413C-BF0C-58E174B2BC71Q38108549-51C70FCD-7C4B-413A-9942-EBB43301962FQ38463350-03449F29-047D-478B-9736-65B552011F04Q38903401-736809DC-4DF7-4C21-891F-182D647A3F4AQ39908771-FCD7BABD-C54C-44A6-BC5E-19B22392335BQ41952193-8E5ADACB-7ABE-448A-BDE3-BAD82E45B61BQ42859553-F047B7A2-3AC9-4B0F-BBE6-3765B0B07B44Q48081438-BB299774-5A8C-4EAF-814C-A1AFDF15B62FQ48090653-54737BF9-52BE-4D7D-A80E-DA72FAFA07A4Q49013090-B8FE0D16-2156-46CE-A9E0-E5ABEA8D5072Q52646203-A10B74DD-38C8-4433-BF67-4A3AEDAC383FQ58207747-462FB66A-A65A-4047-8EE9-536D698A706D
P2860
Safety of therapeutic methylphenidate in adults: a systematic review of the evidence
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Safety of therapeutic methylphenidate in adults: a systematic review of the evidence
@ast
Safety of therapeutic methylphenidate in adults: a systematic review of the evidence
@en
Safety of therapeutic methylphenidate in adults: a systematic review of the evidence
@nl
type
label
Safety of therapeutic methylphenidate in adults: a systematic review of the evidence
@ast
Safety of therapeutic methylphenidate in adults: a systematic review of the evidence
@en
Safety of therapeutic methylphenidate in adults: a systematic review of the evidence
@nl
prefLabel
Safety of therapeutic methylphenidate in adults: a systematic review of the evidence
@ast
Safety of therapeutic methylphenidate in adults: a systematic review of the evidence
@en
Safety of therapeutic methylphenidate in adults: a systematic review of the evidence
@nl
P2860
P356
P1476
Safety of therapeutic methylphenidate in adults: a systematic review of the evidence
@en
P2093
P2860
P304
P356
10.1177/0269881108089809
P407
P577
2009-03-01T00:00:00Z